Initial experience of use of tolvaptan in critically ill patients with fluid overload.
Positive volume balance is related with high mortality in critically ill patients. We describe our experience in the use of tolvaptan in patients with fluid overload. Six patients in the recovery phase from septic shock were included. All patients achieved an increase in diuresis after the first day, with a median fluid balance variation of -2362 (-485 to -3447) mL. At the end of treatment, median fluid balance variation was -9080 (-26,784 to -4395) mL. Tolvaptan could be an option in critically ill patients with fluid overload and resistant or not treatable with conventional diuretics.